PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis

Journal of Autoimmunity

Volumn 35, Issue 4, 2010, Pages 436-442

  Liu, Haiying ^a,b   Norman, Gary L ^c   Shums, Zakera ^c   Worman, Howard J ^d   Krawitt, Edward L ^e   Bizzaro, Nicola ^f   Vergani, Diego ^g   Bogdanos, Dimitrios P ^g   Dalekos, George N ^h   Milkiewicz, Piotr ⁱ   Czaja, Albert J ^j   Heathcote, E Jenny ^k   Hirschfield, Gideon M ^k   Tan, Eng M ^l   Miyachi, Kiyomitsu ^m   Bignotto, Monica ⁿ   Battezzati, Pier Maria ⁿ   Lleo, Ana ^a,n   Leung, Patrick S ^o   Podda, Mauro ^a,n   Gershwin, M Eric ^o   Invernizzi, Pietro ^a,o   more..

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

^c INOVA DIAGNOSTICS INC   (United States)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f Ospedale Civile   (Italy)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

^h UNIVERSITY OF THESSALY   (Greece)

ⁱ POMERANIAN MEDICAL UNIVERSITY   (Poland)

^j MAYO CLINIC   (United States)

^k UNIVERSITY OF TORONTO   (Canada)

^l SCRIPPS RESEARCH INSTITUTE   (United States)

^m Health Sciences Research Institute Inc   (Japan)

ⁿ UNIVERSITY OF MILAN   (Italy)

^o UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Antimitochondrial antibody; Autoantibodies; Biomarkers; Enzyme linked immunosorbent assay (ELISA); Gp210; Sp100

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MITOCHONDRIAL PROTEIN; MITOCHONDRION ANTIBODY; NUCLEAR PROTEIN; PROTEIN MIT3; PROTEIN SP100; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS HEPATITIS;

ANTIGENS, NUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; CLINICAL TRIALS AS TOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDIES; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIKELIHOOD FUNCTIONS; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIAL PROTEINS; NUCLEAR PORE COMPLEX PROTEINS; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77958150189     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.09.005     Document Type: Article

References (40)

1. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
2. Invernizzi P., Selmi C., Ranftler C., Podda M., Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 2005, 25:298-310.
3. Invernizzi P., Lleo A., Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis 2007, 27:161-172.
4. Bogdanos D.P., Invernizzi P., Mackay I.R., Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008, 14:3374-3387.
5. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 2009, 51:237-267.
6. Lindor K.D., Gershwin M.E., Poupon R., Kaplan M., Bergasa N.V., Heathcote E.J. Primary biliary cirrhosis. Hepatology 2009, 50:291-308.
7. Lleo A., Invernizzi P., Gao B., Podda M., Gershwin M.E. Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev 2010, 9:A259-A266.
8. Moteki S., Leung P.S., Coppel R.L., Dickson E.R., Kaplan M.M., Munoz S., et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996, 24:97-103.
9. Oertelt S., Rieger R., Selmi C., Invernizzi P., Ansari A.A., Coppel R.L., et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007, 45:659-665.
10. Dahnrich C., Pares A., Caballeria L., Rosemann A., Schlumberger W., Probst C., et al. New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem 2009, 55:978-985.
11. Courvalin J.C., Lassoued K., Bartnik E., Blobel G., Wozniak R.W. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest 1990, 86:279-285.
12. Szostecki C., Guldner H.H., Netter H.J., Will H. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 1990, 145:4338-4347.
13. Rigopoulou E.I., Davies E.T., Pares A., Zachou K., Liaskos C., Bogdanos D.P., et al. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 2005, 54:528-532.
14. Tartakovsky F., Worman H.J. Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope. Hepatology 1995, 21:495-500.
15. Bandin O., Courvalin J.C., Poupon R., Dubel L., Homberg J.C., Johanet C. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 1996, 23:1020-1024.
16. Wesierska-Gadek J., Penner E., Battezzati P.M., Selmi C., Zuin M., Hitchman E., et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006, 43:1135-1144.
17. Nakamura M., Kondo H., Mori T., Komori A., Matsuyama M., Ito M., et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007, 45:118-127.
18. Ludwig J., Dickson E.R., McDonald G.S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978, 379:103-112.
19. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 2006, 354:54-66.
20. Lee Y.M., Kaplan M.M. Management of primary sclerosing cholangitis. Am J Gastroenterol 2002, 97:528-534.
21. Harada K., Sudo Y., Kono N., Ozaki S., Tsuneyama K., Gershwin M.E., et al. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis. Hepatology 1999, 30:36-45.
22. Szostecki C., Will H., Netter H.J., Guldner H.H. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution. Scand J Immunol 1992, 36:555-564.
23. Bluthner M., Schafer C., Schneider C., Bautz F.A. Identification of major linear epitopes on the sp100 nuclear PBC autoantigen by the gene-fragment phage-display technology. Autoimmunity 1999, 29:33-42.
24. Nickowitz R.E., Worman H.J. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210. J Exp Med 1993, 178:2237-2242.
25. Nishio A., Van de Water J., Leung P.S., Joplin R., Neuberger J.M., Lake J., et al. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology 1997, 25:1085-1089.
26. Malmborg A.C., Shultz D.B., Luton F., Mostov K.E., Richly E., Leung P.S., et al. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. J Autoimmun 1998, 11:573-580.
27. Gabeta S., Norman G.L., Liaskos C., Papamichalis P.A., Zografos T., Garagounis A., et al. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol 2007, 27:378-387.
28. Nakajima M., Shimizu H., Miyazaki A., Watanabe S., Kitami N., Sato N. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?. J Gastroenterol 1999, 34:607-612.
29. Liaskos C., Bogdanos D.P., Rigopoulou E.I., Dalekos G.N. Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact?. J Gastroenterol Hepatol 2007, 22:454-455.
30. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938.
31. Nezu S., Tanaka A., Yasui H., Imamura M., Nakajima H., Ishida H., et al. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol 2006, 21:1448-1454.
32. Vergani D., Alvarez F., Bianchi F.B., Cancado E.L., Mackay I.R., Manns M.P., et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004, 41:677-683.
33. O'Brien C., Joshi S., Feld J.J., Guindi M., Dienes H.P., Heathcote E.J. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 2008, 48:550-556.
34. Kadokawa Y., Omagari K., Hazama H., Ohba K., Masuda J., Kinoshita H., et al. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Clin Biochem 2003, 36:203-210.
35. Miyakawa H., Tanaka A., Kikuchi K., Matsushita M., Kitazawa E., Kawaguchi N., et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001, 34:243-248.
36. Muratori P., Muratori L., Gershwin M.E., Czaja A.J., Pappas G., MacCariello S., et al. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?. Clin Exp Immunol 2004, 135:154-158.
37. Tanaka A., Miyakawa H., Luketic V.A., Kaplan M., Storch W.B., Gershwin M.E. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis. Cell Mol Biol (Noisy-le-grand) 2002, 48:295-299.
38. Kitami N., Komada T., Ishii H., Shimizu H., Adachi H., Yamaguchi Y., et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med 1995, 34:496-501.
39. Hazama H., Omagari K., Masuda J., Ohba K., Kinoshita H., Matsuo I., et al. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis: applications of a routine diagnostic tool for the detection of antimitochondrial antibodies. J Gastroenterol Hepatol 2002, 17:316-323.
40. Invernizzi P., Podda M., Battezzati P.M., Crosignani A., Zuin M., Hitchman E., et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 2001, 34:366-372.